Pharmaceuticals

Global Pharmacovigilance Market Analysis 2025–2029: Opportunities for Strategic Growth

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Pharmacovigilance Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The pharmacovigilance market size has shown significant recent expansion. It is projected to increase from $8.58 billion in 2024 to $9.64 billion in 2025, at a compound annual growth rate (CAGR) of 12.4%. This historical growth can be attributed to the rising incidence of adverse drug reactions (ADRs), heightened research and development (R&D) activities, accelerating drug development rates, a stronger focus on personalized medicine, and the increasing prevalence of chronic diseases.

The pharmacovigilance market is projected to experience substantial expansion over the upcoming years, with its valuation expected to reach $15.5 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.6%. This anticipated growth throughout the forecast period is primarily fueled by escalating healthcare expenditure, increasing governmental assistance, and the growing elderly population. Significant trends during this period are expected to involve a rise in investments, the adoption of artificial intelligence, the utilization of cutting-edge platforms, the deployment of innovative cloud-based systems, and strategic mergers and acquisitions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp

What Are The Drivers Pushing New Developments In The Pharmacovigilance Market?

The expanding scope of research and development activities is anticipated to propel the pharmacovigilance market. By allocating resources to R&D, pharmaceutical companies can formulate innovative drugs characterized by improved safety profiles. Rigorous preclinical and clinical assessments conducted during the drug development phase enable the timely identification of potential safety concerns, thus allowing for the deployment of appropriate risk mitigation strategies. Moreover, R&D efforts contribute to advancements in technologies for monitoring adverse events, analyzing data, and detecting signals, thereby aiding the early detection of adverse drug reactions in the post-marketing phase. For instance, in February 2024, the Llywodraeth Cymru Welsh Government, a UK-based government agency, stated that in 2022, Wales invested £1.0 billion ($1.25 billion) in Business Expenditure on Research and Development (BERD), which constituted 1.9% of the total UK expenditure in this domain. Therefore, the heightened research and development activities have supported the expansion of the pharmacovigilance market.

How Is The Pharmacovigilance Market Classified Into Different Segments?

The pharmacovigilance market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining

2) By Service Provider: In-House, Contract Outsourcing

3) By Process Flow: Case Data Management, Signal Detection, Risk Management System

4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV

5) By End User: Hospitals, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals

2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies

3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs

4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies

5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

What Are The Latest Industry Trends Transforming The Pharmacovigilance Market?

Organizations in the pharmacovigilance industry are directing their attention towards artificial intelligence (AI) to enhance operational efficiency. AI is capable of improving the effectiveness and accuracy of pharmacovigilance activities, ultimately resulting in improved patient outcomes. By leveraging AI, pharmaceutical companies can streamline their processes, better manage data, and accelerate drug discovery, while simultaneously reducing costs and increasing safety. For instance, in August 2024, the Government of India introduced the Adverse Drug Reaction Monitoring System (ADRMS) software, launched by the Minister of Health & Family Welfare and Minister of Chemicals and Fertilizers. This pharmacovigilance software assists in the collection and analysis of adverse events associated with medications and medical devices, thereby simplifying the reporting process for both consumers and healthcare professionals. This initiative considerably strengthens India’s pharmacovigilance infrastructure by ensuring a more comprehensive capture of safety data and improving the monitoring of drug safety. The ADRMS aims to enhance the efficiency of drug safety oversight and compliance with standards, helping to position India as a leader in the global pharmaceutical industry.

Who Are The Top Performing Companies In The Pharmacovigilance Market In Recent Years?

Major companies operating in the pharmacovigilance market include IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation., United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, Wuxi Apptec, Simcere Pharmaceutical Group, Lee’s Pharmaceutical Holdings, Luye Pharma Group, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Alcon, Secure AI Labs, OmniSol dot Tech, Canna Call Company, Veripad, Prevnos Inc., Lifescient, Inc, BeiGene, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., MSD, Novasyte, Fortrea Holdings Inc, Syneos Health Clinical, Zoetis Inc., Telerx Marketing Inc., Gilead Sciences, Inc., Elanco, Abbott Laboratories, Spimaco, Teva Pharmaceutical Industries Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

Which Region Currently Holds The Largest Share Of The Pharmacovigilance Market?

North America was the largest region in the pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Pharmacovigilance Market Report:

https://www.thebusinessresearchcompany.com/customise?id=5928&type=smp

Browse Through More Reports Similar to the Global Pharmacovigilance Market 2025, By The Business Research Company

Pharmaceutical Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report

Pharmaceutical Excipient Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Pharma Microbiology Testing Kits Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharma-microbiology-testing-kits-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795